VPRSX | VSCIX | VPRSX / VSCIX | |
Total Expense Ratio | 0.88 | 0.04 | 2,200% |
Annual Report Gross Expense Ratio | 0.88 | 0.04 | 2,200% |
Fund Existence | 9 years | 28 years | - |
Gain YTD | -8.561 | -7.311 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 311M | 153B | 0% |
Annual Yield % from dividends | 0.56 | 1.53 | 36% |
Returns for 1 year | -3.39 | 0.02 | -17,744% |
Returns for 3 years | -23.58 | 5.01 | -471% |
Returns for 5 years | 50.24 | 112.54 | 45% |
Returns for 10 years | N/A | 89.33 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QLSGX | 25.50 | 0.49 | +1.96% |
Federated Hermes MDT Small Cap Growth R6 | |||
JNGLX | 67.84 | 0.80 | +1.19% |
Janus Henderson Global Life Sciences D | |||
ASQAX | 14.40 | N/A | N/A |
American Century Small Company A | |||
RGLIX | 10.33 | N/A | N/A |
RBC Global Equity Leaders I | |||
THOVX | 38.44 | -0.01 | -0.03% |
Thornburg Global Opportunities R4 |